Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sewoon Medical Co., Ltd. (100700:KRX), powered by AI.
Sewoon Medical Co., Ltd. is currently trading at ₩2,900. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sewoon Medical Co., Ltd. on Alpha Lenz.
Sewoon Medical Co., Ltd.'s P/E ratio is 10.3.
“Sewoon Medical Co., Ltd. trades at a P/E of 10.3 (undervalued) with solid ROE of 8.6%.”
Ask for details →Sewoon Medical Co., Ltd. is a prominent company specializing in the manufacture and distribution of medical supplies and equipment. The company focuses on producing high-quality surgical and medical products that cater to a variety of healthcare sectors. Core offerings include surgical sutures, meshes, and other essential medical devices used in hospitals, clinics, and other healthcare facilities worldwide. By adhering to rigorous quality standards, Sewoon Medical Co., Ltd. ensures the safety and reliability of its products, enhancing patient care and supporting medical professionals in their daily operations. The company plays a significant role in the healthcare industry, contributing to the advancement of medical technology and innovation. Its presence in the market underscores the critical importance of medical supplies in facilitating effective healthcare delivery. Sewoon Medical Co., Ltd., through its consistent dedication to quality and innovation, earns a formidable reputation within both domestic and international markets, ensuring that essential medical resources are accessible and consistently delivered to meet the demands of modern healthcare scenarios.
“Sewoon Medical Co., Ltd. trades at a P/E of 10.3 (undervalued) with solid ROE of 8.6%.”
Ask for details →Sewoon Medical Co., Ltd. (ticker: 100700) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $127.0B.
The current price is ₩2,900 with a P/E ratio of 10.32x and P/B of 0.86x.
ROE is 8.65% and operating margin is 18.91%. Annual revenue is $60.2B.